Investors expect the company's growth to lag behind the indu...
Investors expect the company's growth to lag behind the industry, reflecting in its low P/S ratio. Limited growth rates are anticipated to persist, reducing stock value. If revenue trends continue, share price recovery seems unlikely.
Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Not Doing Enough For Some Investors As Its Shares Slump 25%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment